2023-03-012024-02-292024-02-29false04633828HICKORY HOUSE NURSERY LIMITED2024-12-0985100falseiso4217:GBPxbrli:pure046338282023-03-01046338282024-02-29046338282023-03-012024-02-29046338282022-03-01046338282023-02-28046338282022-03-012023-02-2804633828bus:SmallEntities2023-03-012024-02-2904633828bus:AuditExempt-NoAccountantsReport2023-03-012024-02-2904633828bus:FullAccounts2023-03-012024-02-2904633828bus:PrivateLimitedCompanyLtd2023-03-012024-02-2904633828core:WithinOneYear2024-02-2904633828core:AfterOneYear2024-02-2904633828core:WithinOneYear2023-02-2804633828core:AfterOneYear2023-02-2804633828core:ShareCapital2024-02-2904633828core:SharePremium2024-02-2904633828core:RevaluationReserve2024-02-2904633828core:OtherReservesSubtotal2024-02-2904633828core:RetainedEarningsAccumulatedLosses2024-02-2904633828core:ShareCapital2023-02-2804633828core:SharePremium2023-02-2804633828core:RevaluationReserve2023-02-2804633828core:OtherReservesSubtotal2023-02-2804633828core:RetainedEarningsAccumulatedLosses2023-02-2804633828core:LandBuildings2024-02-2904633828core:PlantMachinery2024-02-2904633828core:Vehicles2024-02-2904633828core:FurnitureFittings2024-02-2904633828core:OfficeEquipment2024-02-2904633828core:NetGoodwill2024-02-2904633828core:IntangibleAssetsOtherThanGoodwill2024-02-2904633828core:ListedExchangeTraded2024-02-2904633828core:UnlistedNon-exchangeTraded2024-02-2904633828core:LandBuildings2023-02-2804633828core:PlantMachinery2023-02-2804633828core:Vehicles2023-02-2804633828core:FurnitureFittings2023-02-2804633828core:OfficeEquipment2023-02-2804633828core:NetGoodwill2023-02-2804633828core:IntangibleAssetsOtherThanGoodwill2023-02-2804633828core:ListedExchangeTraded2023-02-2804633828core:UnlistedNon-exchangeTraded2023-02-2804633828core:LandBuildings2023-03-012024-02-2904633828core:PlantMachinery2023-03-012024-02-2904633828core:Vehicles2023-03-012024-02-2904633828core:FurnitureFittings2023-03-012024-02-2904633828core:OfficeEquipment2023-03-012024-02-2904633828core:NetGoodwill2023-03-012024-02-2904633828core:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2904633828core:ListedExchangeTraded2023-03-012024-02-2904633828core:UnlistedNon-exchangeTraded2023-03-012024-02-2904633828core:MoreThanFiveYears2023-03-012024-02-2904633828core:Non-currentFinancialInstruments2024-02-2904633828core:Non-currentFinancialInstruments2023-02-2804633828dpl:CostSales2023-03-012024-02-2904633828dpl:DistributionCosts2023-03-012024-02-2904633828core:LandBuildings2023-03-012024-02-2904633828core:PlantMachinery2023-03-012024-02-2904633828core:Vehicles2023-03-012024-02-2904633828core:FurnitureFittings2023-03-012024-02-2904633828core:OfficeEquipment2023-03-012024-02-2904633828dpl:AdministrativeExpenses2023-03-012024-02-2904633828core:NetGoodwill2023-03-012024-02-2904633828core:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2904633828dpl:GroupUndertakings2023-03-012024-02-2904633828dpl:ParticipatingInterests2023-03-012024-02-2904633828dpl:GroupUndertakingscore:ListedExchangeTraded2023-03-012024-02-2904633828core:ListedExchangeTraded2023-03-012024-02-2904633828dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-03-012024-02-2904633828core:UnlistedNon-exchangeTraded2023-03-012024-02-2904633828dpl:CostSales2022-03-012023-02-2804633828dpl:DistributionCosts2022-03-012023-02-2804633828core:LandBuildings2022-03-012023-02-2804633828core:PlantMachinery2022-03-012023-02-2804633828core:Vehicles2022-03-012023-02-2804633828core:FurnitureFittings2022-03-012023-02-2804633828core:OfficeEquipment2022-03-012023-02-2804633828dpl:AdministrativeExpenses2022-03-012023-02-2804633828core:NetGoodwill2022-03-012023-02-2804633828core:IntangibleAssetsOtherThanGoodwill2022-03-012023-02-2804633828dpl:GroupUndertakings2022-03-012023-02-2804633828dpl:ParticipatingInterests2022-03-012023-02-2804633828dpl:GroupUndertakingscore:ListedExchangeTraded2022-03-012023-02-2804633828core:ListedExchangeTraded2022-03-012023-02-2804633828dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-03-012023-02-2804633828core:UnlistedNon-exchangeTraded2022-03-012023-02-2804633828core:NetGoodwill2024-02-2904633828core:IntangibleAssetsOtherThanGoodwill2024-02-2904633828core:LandBuildings2024-02-2904633828core:PlantMachinery2024-02-2904633828core:Vehicles2024-02-2904633828core:FurnitureFittings2024-02-2904633828core:OfficeEquipment2024-02-2904633828core:AfterOneYear2024-02-2904633828core:WithinOneYear2024-02-2904633828core:ListedExchangeTraded2024-02-2904633828core:UnlistedNon-exchangeTraded2024-02-2904633828core:ShareCapital2024-02-2904633828core:SharePremium2024-02-2904633828core:RevaluationReserve2024-02-2904633828core:OtherReservesSubtotal2024-02-2904633828core:RetainedEarningsAccumulatedLosses2024-02-2904633828core:NetGoodwill2023-02-2804633828core:IntangibleAssetsOtherThanGoodwill2023-02-2804633828core:LandBuildings2023-02-2804633828core:PlantMachinery2023-02-2804633828core:Vehicles2023-02-2804633828core:FurnitureFittings2023-02-2804633828core:OfficeEquipment2023-02-2804633828core:AfterOneYear2023-02-2804633828core:WithinOneYear2023-02-2804633828core:ListedExchangeTraded2023-02-2804633828core:UnlistedNon-exchangeTraded2023-02-2804633828core:ShareCapital2023-02-2804633828core:SharePremium2023-02-2804633828core:RevaluationReserve2023-02-2804633828core:OtherReservesSubtotal2023-02-2804633828core:RetainedEarningsAccumulatedLosses2023-02-2804633828core:NetGoodwill2022-03-0104633828core:IntangibleAssetsOtherThanGoodwill2022-03-0104633828core:LandBuildings2022-03-0104633828core:PlantMachinery2022-03-0104633828core:Vehicles2022-03-0104633828core:FurnitureFittings2022-03-0104633828core:OfficeEquipment2022-03-0104633828core:AfterOneYear2022-03-0104633828core:WithinOneYear2022-03-0104633828core:ListedExchangeTraded2022-03-0104633828core:UnlistedNon-exchangeTraded2022-03-0104633828core:ShareCapital2022-03-0104633828core:SharePremium2022-03-0104633828core:RevaluationReserve2022-03-0104633828core:OtherReservesSubtotal2022-03-0104633828core:RetainedEarningsAccumulatedLosses2022-03-0104633828core:AfterOneYear2023-03-012024-02-2904633828core:WithinOneYear2023-03-012024-02-2904633828core:Non-currentFinancialInstrumentscore:CostValuation2023-03-012024-02-2904633828core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-012024-02-2904633828core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-012024-02-2904633828core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-012024-02-2904633828core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-012024-02-2904633828core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-012024-02-2904633828core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2904633828core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2904633828core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2904633828core:Non-currentFinancialInstrumentscore:CostValuation2024-02-2904633828core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-2904633828core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-2904633828core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-2904633828core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-2904633828core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-2904633828core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-2904633828core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-2904633828core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-2904633828core:Non-currentFinancialInstrumentscore:CostValuation2023-02-2804633828core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-2804633828core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-2804633828core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-2804633828core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-2804633828core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-2804633828core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-2804633828core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-2804633828core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-2804633828bus:Director12023-03-012024-02-2904633828core:FurnitureFittingsToolsEquipment2023-02-2804633828core:FurnitureFittingsToolsEquipment2023-03-012024-02-2904633828core:FurnitureFittingsToolsEquipment2024-02-29

HICKORY HOUSE NURSERY LIMITED

Registered Number
04633828
(England and Wales)

Unaudited Financial Statements for the Year ended
29 February 2024

HICKORY HOUSE NURSERY LIMITED
Company Information
for the year from 1 March 2023 to 29 February 2024

Director

Sharon Cecilia Crofts

Company Secretary

James Leigh Crofts

Registered Address

5 High Street
Daventry
Northants
NN11 4BG

Registered Number

04633828 (England and Wales)
HICKORY HOUSE NURSERY LIMITED
Balance Sheet as at
29 February 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets4327,786327,887
327,786327,887
Current assets
Debtors58,0977,474
Cash at bank and on hand161,949141,607
170,046149,081
Creditors amounts falling due within one year6(59,168)(50,927)
Net current assets (liabilities)110,87898,154
Total assets less current liabilities438,664426,041
Creditors amounts falling due after one year7(120,808)(135,064)
Provisions for liabilities8(524)(417)
Net assets317,332290,560
Capital and reserves
Called up share capital100100
Profit and loss account317,232290,460
Shareholders' funds317,332290,560
The financial statements were approved and authorised for issue by the Director on 9 December 2024, and are signed on its behalf by:
Sharon Cecilia Crofts
Director
Registered Company No. 04633828
HICKORY HOUSE NURSERY LIMITED
Notes to the Financial Statements
for the year ended 29 February 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Fixtures and fittings20
Office Equipment20
2.Average number of employees

20242023
Average number of employees during the year1314
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 March 2330,00030,000
At 29 February 2430,00030,000
Amortisation and impairment
At 01 March 2330,00030,000
At 29 February 2430,00030,000
Net book value
At 29 February 24--
At 28 February 23--
4.Tangible fixed assets

Land & buildings

Plant & machinery

Fixtures & fittings

Office Equipment

Total

£££££
Cost or valuation
At 01 March 23323,6882,0018,851929335,469
Additions--424-424
At 29 February 24323,6882,0019,275929335,893
Depreciation and impairment
At 01 March 23--7,3971857,582
Charge for year--376149525
At 29 February 24--7,7733348,107
Net book value
At 29 February 24323,6882,0011,502595327,786
At 28 February 23323,6882,0011,454744327,887
5.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables6,5023,985
Other debtors-2,201
Prepayments and accrued income1,5951,288
Total8,0977,474
6.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables128500
Bank borrowings and overdrafts11,96912,543
Taxation and social security20,67311,170
Other creditors21,14620,630
Accrued liabilities and deferred income5,2526,084
Total59,16850,927
7.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts120,808135,064
Total120,808135,064
8.Provisions for liabilities

2024

2023

££
Net deferred tax liability (asset)524417
Total524417